Atlas Trials

PCNSL

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch PCNSL

RecordFirmDate
Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma (NCT05021770)Huiqiang Huang2021-12-01
Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma (NCT04514393)Huiqiang Huang2020-10-10
Rituximab Plus Methotrexate With or Without Lenalidomide in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma (NCT04481815)Second Affiliated Hospital, Zhejiang University, School of Medicine2020-10-01
A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL (NCT04438044)Beijing InnoCare Pharma Tech Co., Ltd.2019-06-18
A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators: (NCT06914700)Guangdong Provincial People's Hospital2016-09-01
Bendamustine-based Combination Therapy for PCNSL (NCT03392714)Chonnam National University Hospital2016-01-20
Prognosis Factors in Patients With Primary Central Nervous System Lymphoma (NCT05167630)Zhengzhou University2013-09-01

Track PCNSL automatically

Every clearance here is in the API, with alerts when new ones post.